In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor
Titel:
In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor
Auteur:
Shoblock, James R. Welty, Natalie Nepomuceno, Diane Lord, Brian Aluisio, Leah Fraser, Ian Motley, S. Timothy Sutton, Steve W. Morton, Kirsten Galici, Ruggero Atack, John R. Dvorak, Lisa Swanson, Devin M. Carruthers, Nicholas I. Dvorak, Curt Lovenberg, Timothy W. Bonaventure, Pascal